Ipca Laboratories Posts Strong Q2 FY27 With Consolidated Net Profit Rising 33% YoY
Ipca Laboratories Ltd 路 Financial Result 路 05 Nov 2026, 7:18 pm
Ipca Laboratories Posts Strong Q2 FY27 With Consolidated Net Profit Rising 33% YoY Ipca Laboratories reported a 14% YoY increase in consolidated revenue from operations to Rs 2,909.94 crore for Q2 ended 30th Sep'26. Consolidated net profit attributable to owners rose 33% YoY to Rs 375.13 crore, driven by a 21% YoY rise in operating EBITDA to Rs 668.27 crore, with EBITDA margin expanding 129 bps YoY to 22.97%. Results include an exceptional provision of Rs 24.26 crore for UK litigation claims. Domestic formulation sales grew 14% YoY to Rs 1,157.20 crore, while total exports expanded 17% YoY.
Original exchange filing (PDF)
More announcements from Ipca Laboratories Ltd
- Transcript of Conference Call held on 05.11.2026 路 06 Nov 2026
- Audio Link of Conference Call held on 05.11.2026 路 05 Nov 2026
- Standalone and Consolidated Financial Results for second quarter and half year ended 30.09.2026 路 05 Nov 2026
- Schedule of Conference Call 路 05 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 05 Nov 2026
- Ipca Laboratories Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 05 Nov 2026
- Ipca Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Standalone and Consolidated .... 路 05 Nov 2026
- Transcript of Conference Call 路 17 Aug 2026
